Emblaveo MDR Infections: Evaluating a New Solut...

By HEOR Staff Writer

November 18, 2025

Emblaveo Approved for MDR Gram-Negative Infections Emblaveo MDR infections pose a growing threat in Portugal, with the public assessment report evaluating Emblaveo (aztreonam + avib...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Lurbinectedin SCLC Therapy: FDA Approval and Its Economic Implications
Pfizer Trump Drug Prices: A Landmark Deal for Affordable Medications
PhRMA’s Patient Access Investment: $500 Billion Commitment to Domestic ...
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
The Market Dynamics of Track One Patent Strategy in Pharmaceuticals
Biosimilars Market Trends 2025: Understanding Erosion and Growth
Mounjaro Price Increase UK: Impacts on Access and Health Economics
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms
Rare Medications Coverage in the Netherlands: Price Reductions Required